Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Schmidt

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Glia|March 1, 2012
Proper cerebellar development requires expression of β1-integrin in Bergmann glia, but not in granule neuronsAlexandra Frick, Daniel Grammel, Felix Schmidt, et al.
Iscience|December 8, 2022
An interoperability framework for multicentric breath metabolomic studiesAmanda Gisler, Kapil Dev Singh, Jiafa Zeng, et al.
Annals of Surgical Oncology|April 27, 2026
A Comparison of 11 Clinical Risk Scores for Prediction of Survival After Curative-Intent Resection of Colorectal Liver MetastasesFelix Schmidt, Franziska A Meister, Lea Hitpass, et al.
Langenbeck'S Archives of Surgery|August 29, 2023
Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastasesIakovos Amygdalos, Lea Hitpass, Felix Schmidt, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 12, 2023
Value of prognostic scoring systems in the era of multimodal therapy for recurrent colorectal liver metastasesKatharina Joechle, Iakovos Amygdalos, Felix Schmidt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2020
[<sup>11</sup>C]MODAG-001-towards a PET tracer targeting α-synuclein aggregatesLaura Kuebler, Sabrina Buss, Andrei Leonov, et al.
Ebiomedicine|May 2, 2022
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJohannes Levin, Nand Sing, Sue Melbourne, et al.
Scientific Reports|December 19, 2022
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synucleinYanina Dening, Theresa Straßl, Viktoria Ruf, et al.
Acta Neuropathologica|February 20, 2025
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's diseaseAlexander M Bernhardt, Sebastian Longen, Svenja V Trossbach, et al.
Clinical Chemistry and Laboratory Medicine|November 2, 2022
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodiesTobias Niedrist, Lisa Kriegl, Christoph J Zurl, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Glia|March 1, 2012
Proper cerebellar development requires expression of β1-integrin in Bergmann glia, but not in granule neuronsAlexandra Frick, Daniel Grammel, Felix Schmidt, et al.
Iscience|December 8, 2022
An interoperability framework for multicentric breath metabolomic studiesAmanda Gisler, Kapil Dev Singh, Jiafa Zeng, et al.
Annals of Surgical Oncology|April 27, 2026
A Comparison of 11 Clinical Risk Scores for Prediction of Survival After Curative-Intent Resection of Colorectal Liver MetastasesFelix Schmidt, Franziska A Meister, Lea Hitpass, et al.
Langenbeck'S Archives of Surgery|August 29, 2023
Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastasesIakovos Amygdalos, Lea Hitpass, Felix Schmidt, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 12, 2023
Value of prognostic scoring systems in the era of multimodal therapy for recurrent colorectal liver metastasesKatharina Joechle, Iakovos Amygdalos, Felix Schmidt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2020
[<sup>11</sup>C]MODAG-001-towards a PET tracer targeting α-synuclein aggregatesLaura Kuebler, Sabrina Buss, Andrei Leonov, et al.
Ebiomedicine|May 2, 2022
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJohannes Levin, Nand Sing, Sue Melbourne, et al.
Scientific Reports|December 19, 2022
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synucleinYanina Dening, Theresa Straßl, Viktoria Ruf, et al.
Acta Neuropathologica|February 20, 2025
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's diseaseAlexander M Bernhardt, Sebastian Longen, Svenja V Trossbach, et al.
Clinical Chemistry and Laboratory Medicine|November 2, 2022
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodiesTobias Niedrist, Lisa Kriegl, Christoph J Zurl, et al.
Pageof 9